China CAS NO 16617-46-2 Factory

Our products are extensively identified and reliable by consumers and will satisfy constantly developing economic and social desires for CAS NO 16617-46-2,16617-46-2,Ibrutinib intermediate,Ibrutinib advance intermediate,3-Amino-4-pyrazolecarbonitrile, Special emphasis around the packaging of merchandise to avoid any damage during transportation,Detailed interest into the useful feedback and strategies of our esteemed shoppers.
CAS NO 16617-46-2, With many years good service and development, we've a professional international trade sales team. Our products have exported to North America, Europe, Japan, Korea, Australia, New Zealand, Russia and other countries. Looking forward to build up a good and long term cooperation with you in coming future!

Hot Products

  • Methyl (R)-(-)-3-hydroxybutyrate

    Methyl (R)-(-)-3-hydroxybutyrate

    Product Name:Methyl (R)-(-)-3-hydroxybutyrate
    Molecular Formula:C5H10O3
    Molecular Weight:118.13
    CAS Registry Number:3976-69-0
  • 2-Chloro-5-fluoronicotinic acid

    2-Chloro-5-fluoronicotinic acid

    Product Name:2-Chloro-5-fluoronicotinic acid
    Molecular Formula:C6H3ClFNO2
    Molecular Weight:175.54
    CAS Registry Number:38186-88-8
  • Regorafenib

    Regorafenib

    Product Name:Regorafenib
    Molecular Formula:C21H15ClF4N4O3
    Molecular Weight;482.82
    CAS Registry Number;755037-03-7
  • trans-4-Phenyl-L-proline

    trans-4-Phenyl-L-proline

    Product Name:trans-4-Phenyl-L-proline
    Molecular Formula:C11H13NO2
    Molecular Weight:191.23
    CAS Registry Number:96314-26-0
  • Clozapine

    Clozapine

    Product Name:Clozapine
    Molecular Formula:C18H19ClN4
    Molecular Weight;326.82
    CAS Registry Number;5786-21-0
  • Pro-xylane

    Pro-xylane

    Product Name:Pro-xylane
    Molecular Formula:C8H16O5
    Molecular Weight:192.21
    CAS Registry Number:439685-79-7

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept